Prevalence and impact of myocardial injury among patients hospitalized with COVID-19

Background Myocardial injury is a prevalent complication observed in patients hospitalized with COVID-19 and is strongly associated with severe illness and in-hospital mortality. However, the long-term consequences of myocardial injury on clinical outcomes remain poorly understood. This study aimed to assess the impact of myocardial injury on both acute-phase and long-term prognosis in COVID-19 patients. Methods A retrospective, observational study was conducted on all patients who received treatment at the Intensive Care Center for COVID-19 patient, University Medical Center Ho Chi Minh City (UCICC), from August 3rd, 2021, to October 28th, 2021. Results A total of 582 patients were enrolled in the study, of which 55.3% were female. The mean age of participants was 63.3 ± 16.2. Out of these patients, 330 cases (56.8%) showed myocardial injury. Compared to patients without myocardial injury, those with myocardial injury were older and had a higher incidence of chronic diseases including hypertension, ischemic heart disease, atrial fibrillation, heart failure, diabetes mellitus, chronic kidney disease. They also presented with more severe respiratory failure upon admission and showed a more pronounced abnormality in inflammation and kidney function tests. Furthermore, the in-hospital mortality rate was significantly higher in the group with myocardial injury (49.7% vs 14.3%, p < 0.001). After adjusting for age, gender, comorbidities, renal function, and disease severity at admission, myocardial injury emerged as an independent risk factor for in-hospital mortality (OR = 3.758, 95% CI 1.854–7.678, p < 0.001). Among successfully discharged COVID-19 patients, the all-cause mortality rate after a median follow-up of 18.4 months was 7.9%. Patients with myocardial injury had a significantly higher long-term mortality rate compared to those without myocardial injury (14.0% vs. 3.2%, p < 0.001). However, multivariable Cox regression analysis did not find myocardial injury to be a significant predictor of long-term mortality (HR = 2.128, 95% CI 0.792–5.712, p = 0.134). Conclusions Myocardial injury is a common and serious complication in hospitalized COVID-19 patients, associated with increased in-hospital mortality. However, it does not significantly impact long-term mortality in successfully discharged COVID-19 patients.

[1]  Z. Raisi-Estabragh,et al.  Editorial: Post-COVID-19 cardiovascular sequelae , 2023, Frontiers in Cardiovascular Medicine.

[2]  A. Gasbarrini,et al.  Myocardial Injury Portends a Higher Risk of Mortality and Long-Term Cardiovascular Sequelae after Hospital Discharge in COVID-19 Survivors , 2022, Journal of clinical medicine.

[3]  J. Sorkin,et al.  Mid-term Surgery Outcomes in Patients With COVID-19 , 2022, Annals of surgery.

[4]  B. Vaquerizo,et al.  Myocardial Injury in COVID-19 and Its Implications in Short- and Long-Term Outcomes , 2022, Frontiers in Cardiovascular Medicine.

[5]  N. Horita,et al.  Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis , 2022, Heart and Vessels.

[6]  Benjamin Bowe,et al.  Long-term cardiovascular outcomes of COVID-19 , 2022, Nature Medicine.

[7]  V. Ferrari,et al.  The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury , 2022, JACC: Basic to Translational Science.

[8]  R. Fleysher,et al.  Clinical predictors of acute cardiac injury and normalization of troponin after hospital discharge from COVID-19 , 2022, eBioMedicine.

[9]  F. Sanz,et al.  Acute Myocardial Injury During SARS-CoV-2 Pneumonia and Long-term Prognosis , 2022, Journal of General Internal Medicine.

[10]  Deepak L. Bhatt,et al.  Relationship Between Myocardial Injury During Index Hospitalization for SARS‐CoV‐2 Infection and Longer‐Term Outcomes , 2021, Journal of the American Heart Association.

[11]  Arthur S Slutsky,et al.  Acute Cardiac Injury in Coronavirus Disease 2019 and Other Viral Infections—A Systematic Review and Meta-Analysis , 2021, Critical care medicine.

[12]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[13]  M. Dimopoulos,et al.  Predictors of adverse prognosis in COVID‐19: A systematic review and meta‐analysis , 2020, European journal of clinical investigation.

[14]  A. Jaffe,et al.  Cardiac Troponin for Assessment of Myocardial Injury in COVID-19 , 2020, Journal of the American College of Cardiology.

[15]  K. Ferdinand,et al.  Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID‐19 patients: A meta‐regression and decision tree analysis , 2020, Journal of medical virology.

[16]  Kipp W. Johnson,et al.  Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection , 2020, Journal of the American College of Cardiology.

[17]  Deepak L. Bhatt,et al.  Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review , 2020, Progress in Cardiovascular Diseases.

[18]  S. Cao,et al.  Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019 , 2020, European heart journal.

[19]  Tao Guo,et al.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[20]  W. Gong,et al.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.

[21]  Simon Redwood,et al.  Coronaviruses and the cardiovascular system: acute and long-term implications , 2020, European heart journal.

[22]  G. Lippi,et al.  Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis , 2020, Progress in Cardiovascular Diseases.

[23]  China Cdc Weekly The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020 , 2020, China CDC weekly.

[24]  Novel Coronavirus Pneumonia Emergency Response Epidemiol Team [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[25]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[26]  M. Fine,et al.  Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America , 2019, American journal of respiratory and critical care medicine.

[27]  Yaiza Beatriz Molero-Díez,et al.  Fourth universal definition of myocardial infarction , 2019, Colombian Journal of Anesthesiology.

[28]  Ge Gui,et al.  A systematic review and meta-analysis , 2017 .

[29]  B. Lewis,et al.  [The new universal definition of myocardial infarction]. , 2009, Harefuah.

[30]  J. Galloway A Review of the , 1901 .

[31]  J. E. Barone,et al.  A Meta-Analysis , 2022 .